These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 848925)

  • 21. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sensitivity and resistance of pathogenic yeasts to 5-fluoropyrimidines. II.--Mechanisms of resistance to 5-fluorocytosine (5-FC) and 5-fluorouracil (5-FU) (author's transl)].
    Montplaisir S; Drouhet E; Mercier-Soucy L
    Ann Microbiol (Paris); 1975; 126B(1):41-9. PubMed ID: 1211721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
    Rumler W; Heins S; Heins J
    Mykosen; 1984 Sep; 27(9):436-42. PubMed ID: 6390193
    [No Abstract]   [Full Text] [Related]  

  • 24. Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
    Myoken Y; Sugata T; Myoken Y; Kyo T; Fujihara M; Mikami Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Feb; 87(2):174-9. PubMed ID: 10052372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitivity of yeasts against 5 fluorocytosine. Comparison of five methods (author's transl)].
    Brinkmann F
    Z Hautkr; 1981 Oct; 56(19):1255-63. PubMed ID: 7032101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
    Nobre G; Sobral T; Ferreira AF
    Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-beta-(2S,4S)- and L-alpha-(2S,4R)-dioxolanyl nucleosides as potential anti-HIV agents: asymmetric synthesis and structure-activity relationships.
    Kim HO; Schinazi RF; Shanmuganathan K; Jeong LS; Beach JW; Nampalli S; Cannon DL; Chu CK
    J Med Chem; 1993 Mar; 36(5):519-28. PubMed ID: 8496934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods.
    Lewis RE; Klepser ME; Pfaller MA
    Diagn Microbiol Infect Dis; 2000 Feb; 36(2):101-5. PubMed ID: 10705051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL; Kerridge D
    Antimicrob Agents Chemother; 1984 Oct; 26(4):570-4. PubMed ID: 6393861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of serum 5-fluorocytosine concentrations in the presence of ketoconazole.
    Roselle GA; Warth P
    J Antimicrob Chemother; 1983 Aug; 12(2):189-92. PubMed ID: 6311787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mode of action of 5-fluorocytosine and mechanisms of resistance.
    Polak A; Scholer HJ
    Chemotherapy; 1975; 21(3-4):113-30. PubMed ID: 1098864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of reduced oxygen on the antifungal susceptibility of clinically relevant aspergilli.
    Binder U; Maurer E; Lackner M; Lass-Flörl C
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1806-10. PubMed ID: 25547350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
    Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW
    J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of antifungal agents against clinical isolates of aspergilli.
    Otcenásek M
    Zentralbl Bakteriol; 1992 Jun; 277(1):100-5. PubMed ID: 1520959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology.
    Meletiadis J; Antachopoulos C; Stergiopoulou T; Pournaras S; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3329-37. PubMed ID: 17576838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-fluorocytosine susceptibility of pathogenic fungi in the presence of allopurinol: potential for improving the therapeutic index of 5-fluorocytosine.
    Kerkering TM; Schwartz PM; Espinel-Ingroff A; Turek PJ; Diasio RB
    Antimicrob Agents Chemother; 1983 Sep; 24(3):448-9. PubMed ID: 6639003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on deamination of 5-fluorocytosine in fungal cells.
    Pawlik B; Barylak J
    Mykosen; 1979 Sep; 22(9):328-35. PubMed ID: 530295
    [No Abstract]   [Full Text] [Related]  

  • 39. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH; Sarosi GA
    Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 19F nuclear magnetic resonance study of uptake and metabolism of 5-fluorocytosine in susceptible and resistant strains of Candida albicans.
    Di Vito M; Podo F; Torosantucci A; Carpinelli G; Whelan WL; Kerridge D; Cassone A
    Antimicrob Agents Chemother; 1986 Feb; 29(2):303-8. PubMed ID: 3521476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.